Antibodies Assay Kits Bap1 Antibody Biology Cells Brd4 Antibody Fto Antibody Gels Glut2 Antibody Gsk3 Alpha Hama Antibodies PCR Rbpj Antibody Reagents Recombinant Proteins Ria Kits Vector & Virus Vi Alpha Vitronectin Antibody Western Blot
Mutational bias in spermatogonia impacts the anatomy of regulatory sites in the human genome
Mutation within the germline is the final word supply of genetic variation, however little is thought concerning the affect of germline chromatin construction on mutational processes. Utilizing ATAC-seq, we profile the open chromatin panorama of human spermatogonia, probably the most proliferative cell kind of the germline, figuring out transcription issue binding websites (TFBSs) and PRDM9-binding websites, a subset of which is able to provoke meiotic recombination.
We observe a rise in uncommon structural variant (SV) breakpoints at PRDM9-bound websites, implicating meiotic recombination within the technology of structural variation. Many germline TFBSs, equivalent to NRF1, are additionally related to elevated charges of SV breakpoints, apparently unbiased of recombination.
Singleton brief insertions (>=5 bp) are extremely enriched at TFBSs, significantly at websites sure by testis energetic TFs, and their charges correlate with these of structural variant breakpoints. Quick insertions typically duplicate the TFBS motif, resulting in clustering of motif websites close to regulatory areas on this male-driven evolutionary course of.
Elevated mutation masses at germline TFBSs disproportionately have an effect on neural enhancers with exercise in spermatogonia, doubtlessly altering neurodevelopmental regulatory structure. Native chromatin construction in spermatogonia is thus pervasive in shaping each evolution and illness.
Human-Related Mechanisms and Threat Elements for TAK-875-Induced Liver Harm Recognized through a Gene Pathway-Based mostly Method in Collaborative Cross Mice
Improvement of TAK-875 was discontinued when a small variety of critical drug-induced liver harm (DILI) circumstances had been noticed in Section Three scientific trials. Subsequent research have recognized hepatocellular oxidative stress, mitochondrial dysfunction, altered bile acid homeostasis, and immune response as mechanisms of TAK-875 DILI and the contribution of genetic threat elements in oxidative response and mitochondrial pathways to the toxicity susceptibility noticed in sufferers.
We examined the speculation {that a} novel preclinical method primarily based on gene pathway evaluation within the livers of Collaborative Cross mice may very well be used to determine human-relevant mechanisms of toxicity and genetic threat elements on the stage of the hepatocyte as reported in a human genome-wide affiliation research.
Eight (8) male mice (four matched pairs) from every of 45 Collaborative Cross strains had been handled with a single oral (gavage) dose of both car or 600 mg/kg TAK-875. As anticipated, liver harm was not detected histologically and few modifications in plasma biomarkers of hepatotoxicity had been noticed.
Nevertheless, gene expression profiling within the liver recognized tons of of transcripts conscious of TAK-875 remedy throughout all strains reflecting alterations in immune response and bile acid homeostasis and the interplay of remedy and pressure reflecting oxidative stress and mitochondrial dysfunction.
Fold-change expression values had been then used to develop pathway-based phenotypes for genetic mapping which recognized candidate threat issue genes for TAK-875 toxicity susceptibility on the stage of the hepatocyte.
Taken collectively, these findings help our speculation {that a} gene pathway-based method utilizing Collaborative Cross mice may inform delicate strains, human-relevant mechanisms of toxicity, and genetic threat elements for TAK-875 DILI. This novel preclinical method could also be useful in understanding, predicting, and in the end stopping scientific DILI for different medication.
Minimal physiologically primarily based pharmacokinetic-pharmacodynamic (mPBPK-PD) mannequin of GalNAc-conjugated siRNA disposition and gene silencing in preclinical species and people
Conjugation of small interfering ribonucleic acid (siRNA) to tris-N-acetylgalactosamine (tris-GalNAc) can allow extremely selective, potent, and sturdy knockdown of focused proteins within the liver. Nevertheless, potential information gaps between in vitro experiments, preclinical species, and scientific eventualities stay.
A minimal physiologically primarily based pharmacokinetic-pharmacodynamic (mPBPK-PD) mannequin for GalNAc-conjugated siRNA (GalNAc-siRNA) was developed utilizing printed information for fitusiran (ALN-AT3), an investigational compound focusing on liver antithrombin (AT), to delineate putative determinants governing the entire body-to-cellular PK-PD of GalNAc-siRNA and facilitate preclinical-to-clinical translation.
The mannequin mathematically linked related mechanisms: i) hepatic biodistribution, ii) tris-GalNAc binding to asialoglycoprotein receptors (ASGPRs) on hepatocytes, iii) ASGPR endocytosis and recycling, iv) endosomal transport and escape of siRNA, v) cytoplasmic RNA-induced silencing complicated (RISC) loading, vi) degradation of goal mRNA by sure RISC, and vii) knockdown of protein.
Physiological values for 36 out of 48 mannequin parameters had been obtained from the literature. Kinetic parameters governing (GalNAc)3-ASGPR binding and internalization had been derived from printed research of uptake in hepatocytes.
The proposed mannequin nicely characterised reported PK, RISC dynamics, and knockdown of AT mRNA and protein by ALN-AT3 in mice. The mannequin bridged a number of PK-PD datasets in preclinical species (mice, rat, monkey) and efficiently captured reported plasma PK and AT knockdown in a Section-I ascending dose research. Estimates of in vivo efficiency (SC50 ) had been related (~2-fold) throughout species.
Subcutaneous absorption and serum AT degradation charge constants scaled throughout species by physique weight with allometric exponents of -0.29 and -0.22. The proposed mechanistic modeling framework characterizes the distinctive PK-PD properties of GalNAc-siRNA. Significance Assertion (GalNAc)3-conjugated siRNA therapeutics allow liver-targeted gene remedy and precision drugs.
Utilizing a translational and systems-based minimal physiologically primarily based pharmacokinetic-pharmacodynamic (mPBPK-PD) modeling method, drug- and system-specific determinants influencing GalNAc-siRNA performance in preclinical species (mice, rats, monkeys) and people had been investigated.
The developed mannequin efficiently built-in and characterised related printed in vitro-derived biomeasures, mechanistic PK-PD profiles in animals, and noticed scientific PK-PD responses for an investigational GalNAc-siRNA (fitusiran). This modeling effort delineates the entire body-to-cellular disposition and liver-targeted pharmacodynamics of GalNAc-siRNA.
Entire Genome Sequencing Hyperlinks Mycobacterium bovis From Cattle, Cheese and People in Baja California, Mexico
Mycobacterium bovis causes tuberculosis (TB) in cattle, which in flip can transmit the pathogen to people. Tuberculosis in dairy cattle is of explicit concern the place the consumption of uncooked milk and dairy merchandise is customary. Baja California (BCA), Mexico, presents excessive prevalence of TB in each cattle and people, making it vital to analyze the molecular epidemiology of the illness within the area.
An extended-term research was undertaken to totally characterize the variety of M. bovis genotypes circulating in dairy cattle, cheese and people in BCA by whole-genome sequencing (WGS). Throughout a 2-year interval, 412 granulomatous tissue samples had been collected from native abattoirs and 314 cheese samples had been bought from native shops and distributors in BCA and despatched to the laboratory for mycobacterial tradition, histology, direct PCR and WGS. For tissue samples M. bovis was recovered from 86.8%, direct PCR detected 90% and histology confirmed 85.9% as mycobacteriosis-compatible.
For cheese, M. bovis was recovered from 2.5% and direct PCR detected 6% of the samples. There was good settlement between diagnostic exams. Subsequently, a complete of 345 whole-genome SNP sequences had been obtained. Phylogenetic evaluation grouped these isolates into 10 main clades. SNP evaluation revealed putative transmission clusters the place the pairwise SNP distance between isolates from totally different dairies was ≤Three SNP.
Additionally, human and/or cheese isolates had been inside 8.45 (vary 0-17) and 5.Eight SNP (vary 0-15), respectively, from cattle isolates. Lastly, a comparability between the genotypes obtained on this research and people reported beforehand means that the genetic variety of M. bovis in BCA is well-characterized, and can be utilized to find out if BCA is the seemingly supply of M. bovis in people and cattle in routine epidemiologic investigations and future research. In conclusion,
Recombinant Hepatitis C Virus NS5 Genotype-1b |
|||
| 7-07342 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-1b |
|||
| 7-07343 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-1b |
|||
| 7-07344 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-1b |
|||
| 7-07177 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-1b |
|||
| 7-07178 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-1b |
|||
| 7-07179 | CHI Scientific | 1000µg | Ask for price |
Hepatitis C Virus NS3 Genotype-1b protein |
|||
| 30R-AH052 | Fitzgerald | 500 ug | EUR 967.2 |
|
Description: Hepatitis C Virus NS3 Genotype-1b recombinant protein |
|||
Hepatitis C Virus NS3 Genotype-1b Protein |
|||
| 20-abx260126 | Abbexa |
|
|
Hepatitis C Virus NS5 Genotype-1b Protein |
|||
| 20-abx260240 | Abbexa |
|
|
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) polyprotein, His, Yeast-100ug |
|||
| QP9739-ye-100ug | EnQuireBio | 100ug | EUR 945.6 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) polyprotein, His, Yeast-10ug |
|||
| QP9739-ye-10ug | EnQuireBio | 10ug | EUR 434.4 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) polyprotein, His, Yeast-1mg |
|||
| QP9739-ye-1mg | EnQuireBio | 1mg | EUR 3296.4 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) polyprotein, His, Yeast-200ug |
|||
| QP9739-ye-200ug | EnQuireBio | 200ug | EUR 1512 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) polyprotein, His, Yeast-500ug |
|||
| QP9739-ye-500ug | EnQuireBio | 500ug | EUR 2164.8 |
Recombinant Hepatitis C virus genotype 1b (strain HC-J4) polyprotein, His, Yeast-50ug |
|||
| QP9739-ye-50ug | EnQuireBio | 50ug | EUR 576 |
Recombinant Hepatitis C Virus NS3 Genotype-1b (1192-1459) |
|||
| 7-07243 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus NS3 Genotype-1b (1192-1459) |
|||
| 7-07244 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus NS3 Genotype-1b (1192-1459) |
|||
| 7-07245 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus NS3 Genotype-1b (1356-1459) |
|||
| 7-07249 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus NS3 Genotype-1b (1356-1459) |
|||
| 7-07250 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus NS3 Genotype-1b (1356-1459) |
|||
| 7-07251 | CHI Scientific | 1000µg | Ask for price |
Recombinant (E.Coli) Hepatitis C Virus (HCV) Nucleocapsid (core) Genotype-1b |
|||
| RP-503 | Alpha Diagnostics | 100 ug | EUR 343.2 |
Hepatitis C Virus NS3 Genotype-1b (1192-1459) Protein |
|||
| 20-abx260250 | Abbexa |
|
|
Hepatitis C Virus NS3 Genotype-1b (1356-1459) Protein |
|||
| 20-abx260252 | Abbexa |
|
|
Japanese encephalitis virus Genome polyprotein |
|||
| 1-CSB-EP189574Ba | Cusabio |
|
|
|
Description: Recombinant Japanese encephalitis virus Genome polyprotein,partial expressed in E.coli |
|||
Yellow fever virus Genome polyprotein |
|||
| 1-CSB-EP365905YAC1 | Cusabio |
|
|
|
Description: Recombinant Yellow fever virus Genome polyprotein,partial expressed in E.coli |
|||
Recombinant (E.Coli, His-tag) Hepatitis C Virus (HCV) NS3 Genotype-1b |
|||
| RP-461 | Alpha Diagnostics | 100 ug | EUR 343.2 |
Recombinant (E.Coli, GST tag) Hepatitis C Virus (HCV) NS5 Genotype-1b |
|||
| RP-486 | Alpha Diagnostics | 100 ug | EUR 343.2 |
Recombinant (E.Coli) Hepatitis C Virus (HCV) NS3 Genotype-1b (1192-1459) |
|||
| RP-505 | Alpha Diagnostics | 100 ug | EUR 343.2 |
Recombinant (E.Coli) Hepatitis C Virus (HCV) NS3 Genotype-1b (1356-1459) |
|||
| RP-507 | Alpha Diagnostics | 100 ug | EUR 343.2 |
Recombinant Hepatitis C Virus NS3 Genotype-1c |
|||
| 7-07252 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus NS3 Genotype-1c |
|||
| 7-07253 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus NS3 Genotype-1c |
|||
| 7-07254 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus NS3 Genotype-5a |
|||
| 7-07279 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus NS3 Genotype-5a |
|||
| 7-07280 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus NS3 Genotype-5a |
|||
| 7-07281 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-1 |
|||
| 7-07333 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-1 |
|||
| 7-07334 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-1 |
|||
| 7-07335 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-1a |
|||
| 7-07339 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-1a |
|||
| 7-07340 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-1a |
|||
| 7-07341 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-2 |
|||
| 7-07345 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-2 |
|||
| 7-07346 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-2 |
|||
| 7-07347 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-2a |
|||
| 7-07348 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-2a |
|||
| 7-07349 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-2a |
|||
| 7-07350 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-2b |
|||
| 7-07351 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-2b |
|||
| 7-07352 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-2b |
|||
| 7-07353 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-3 |
|||
| 7-07354 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-3 |
|||
| 7-07355 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-3 |
|||
| 7-07356 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-3a |
|||
| 7-07357 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-3a |
|||
| 7-07358 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-3a |
|||
| 7-07359 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-3b |
|||
| 7-07360 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-3b |
|||
| 7-07361 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-3b |
|||
| 7-07362 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-4 |
|||
| 7-07363 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-4 |
|||
| 7-07364 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-4 |
|||
| 7-07365 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-5 |
|||
| 7-07366 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-5 |
|||
| 7-07367 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-5 |
|||
| 7-07368 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-6 |
|||
| 7-07369 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-6 |
|||
| 7-07370 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-6 |
|||
| 7-07371 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-6a |
|||
| 7-07372 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-6a |
|||
| 7-07373 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus NS5 Genotype-6a |
|||
| 7-07374 | CHI Scientific | 1000µg | Ask for price |
Hepatitis E virus genotype 1 Non-structural polyprotein pORF1 (ORF1) |
|||
| 1-CSB-EP327230HGE | Cusabio |
|
|
|
Description: Recombinant Hepatitis E virus genotype 1 Non-structural polyprotein pORF1(ORF1),partial expressed in E.coli |
|||
Recombinant Hepatitis C virus genotype 1a (isolate 1) polyprotein, His-SUMO, Mammal-10ug |
|||
| QP6996-10ug | EnQuireBio | 10ug | EUR 426 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) polyprotein, His-SUMO, Mammal-1mg |
|||
| QP6996-1mg | EnQuireBio | 1mg | EUR 3037.2 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) polyprotein, His-SUMO, Mammal-200ug |
|||
| QP6996-200ug | EnQuireBio | 200ug | EUR 1468.8 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) polyprotein, His-SUMO, Mammal-20ug |
|||
| QP6996-20ug | EnQuireBio | 20ug | EUR 523.2 |
Recombinant Hepatitis C virus genotype 1a (isolate 1) polyprotein, His-SUMO, Mammal-500ug |
|||
| QP6996-500ug | EnQuireBio | 500ug | EUR 1936.8 |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-100ug |
|||
| QP8939-ec-100ug | EnQuireBio | 100ug | EUR 848.4 |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-10ug |
|||
| QP8939-ec-10ug | EnQuireBio | 10ug | EUR 391.2 |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-1mg |
|||
| QP8939-ec-1mg | EnQuireBio | 1mg | EUR 2763.6 |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-200ug |
|||
| QP8939-ec-200ug | EnQuireBio | 200ug | EUR 1338 |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-500ug |
|||
| QP8939-ec-500ug | EnQuireBio | 500ug | EUR 1816.8 |
Recombinant Hepatitis C Virus polyprotein, His, E.coli-50ug |
|||
| QP8939-ec-50ug | EnQuireBio | 50ug | EUR 522 |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-1 |
|||
| 7-07171 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-1 |
|||
| 7-07172 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-1 |
|||
| 7-07173 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-1a |
|||
| 7-07174 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-1a |
|||
| 7-07175 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-1a |
|||
| 7-07176 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-2a |
|||
| 7-07180 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-2a |
|||
| 7-07181 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-2a |
|||
| 7-07182 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-2b |
|||
| 7-07183 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-2b |
|||
| 7-07184 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-2b |
|||
| 7-07185 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-3a |
|||
| 7-07186 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-3a |
|||
| 7-07187 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-3a |
|||
| 7-07188 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-3b |
|||
| 7-07189 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-3b |
|||
| 7-07190 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-3b |
|||
| 7-07191 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-4 |
|||
| 7-07192 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-4 |
|||
| 7-07193 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-4 |
|||
| 7-07194 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-5 |
|||
| 7-07195 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-5 |
|||
| 7-07196 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-5 |
|||
| 7-07197 | CHI Scientific | 1000µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-6a |
|||
| 7-07198 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-6a |
|||
| 7-07199 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis C Virus Nucleocapsid (core) Genotype-6a |
|||
| 7-07200 | CHI Scientific | 1000µg | Ask for price |
Recombinant Mosaic Hepatitis C Virus NS4 Genotype-1 |
|||
| 7-07303 | CHI Scientific | 100µg | Ask for price |
Recombinant Mosaic Hepatitis C Virus NS4 Genotype-1 |
|||
| 7-07304 | CHI Scientific | 500µg | Ask for price |
Recombinant Mosaic Hepatitis C Virus NS4 Genotype-1 |
|||
| 7-07305 | CHI Scientific | 1000µg | Ask for price |
Recombinant Mosaic Hepatitis C Virus NS4 Genotype-2 |
|||
| 7-07306 | CHI Scientific | 100µg | Ask for price |
Recombinant Mosaic Hepatitis C Virus NS4 Genotype-2 |
|||
| 7-07307 | CHI Scientific | 500µg | Ask for price |
Recombinant Mosaic Hepatitis C Virus NS4 Genotype-2 |
|||
| 7-07308 | CHI Scientific | 1000µg | Ask for price |
Recombinant Mosaic Hepatitis C Virus NS4 Genotype-3 |
|||
| 7-07309 | CHI Scientific | 100µg | Ask for price |
Recombinant Mosaic Hepatitis C Virus NS4 Genotype-3 |
|||
| 7-07310 | CHI Scientific | 500µg | Ask for price |
Recombinant Mosaic Hepatitis C Virus NS4 Genotype-3 |
|||
| 7-07311 | CHI Scientific | 1000µg | Ask for price |
Recombinant Mosaic Hepatitis C Virus NS4 Genotype-5 |
|||
| 7-07312 | CHI Scientific | 100µg | Ask for price |
Recombinant Mosaic Hepatitis C Virus NS4 Genotype-5 |
|||
| 7-07313 | CHI Scientific | 500µg | Ask for price |
Recombinant Mosaic Hepatitis C Virus NS4 Genotype-5 |
|||
| 7-07314 | CHI Scientific | 1000µg | Ask for price |
Recombinant (E.Coli, GST-tag) Hepatitis C Virus (HCV) NS5, Biotin Labled, Genotype-1b |
|||
| RP-494 | Alpha Diagnostics | 50 ug | EUR 343.2 |
Genome polyprotein Antibody |
|||
| 1-CSB-PA18549A0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody |
|||
| 1-CSB-PA333180LA01HFD | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody |
|||
| 1-CSB-PA362073LA01HQD | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
Genome polyprotein Antibody |
|||
| 1-CSB-PA714772LA01HYH | Cusabio |
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
Genome Polyprotein Antibody |
|||
| 20-abx109417 | Abbexa |
|
|
Genome polyprotein Antibody |
|||
| 20-abx300967 | Abbexa |
|
|
Hepatitis C Virus NS3 Genotype 1a protein |
|||
| 30R-AH005 | Fitzgerald | 1 mg | EUR 1844.4 |
|
Description: Purified recombinant Hepatitis C Virus NS3 Genotype 1a protein |
|||
Hepatitis C Virus NS3 Genotype 2b protein |
|||
| 30R-AH006 | Fitzgerald | 500 ug | EUR 967.2 |
|
Description: Purified recombinant Hepatitis C Virus NS3 Genotype 2b protein |
|||
Hepatitis C Virus NS5 Genotype 2a protein |
|||
| 30R-AH010 | Fitzgerald | 500 ug | EUR 949.2 |
|
Description: Hepatitis C Virus NS5 Genotype-2a recombinant protein |
|||
Hepatitis C Virus Nucleocpasid Genotype 2a protein |
|||
| 30R-AH011 | Fitzgerald | 500 ug | EUR 949.2 |
|
Description: Hepatitis C Virus Core Genotype-2a recombinant protein |
|||
Hepatitis C Virus NS5 Genotype 1 protein |
|||
| 30R-AH051 | Fitzgerald | 1 mg | EUR 1567.2 |
|
Description: Hepatitis C Virus NS5 Genotype-1 recombinant protein |
|||
Hepatitis C Virus NS4 Genotype 1 protein |
|||
| 30R-AH057 | Fitzgerald | 100 ug | EUR 548.4 |
|
Description: Hepatitis C Virus NS4 Mosaic Genotype-1 recombinant protein |
|||
Hepatitis C Virus NS4 Genotype 2 protein |
|||
| 30R-AH058 | Fitzgerald | 100 ug | EUR 548.4 |
|
Description: Hepatitis C Virus NS4 Mosaic Genotype-2 recombinant protein |
|||
Hepatitis C Virus NS4 Genotype 3 protein |
|||
| 30R-AH059 | Fitzgerald | 100 ug | EUR 548.4 |
|
Description: Hepatitis C Virus NS4 Mosaic Genotype-3 recombinant protein |
|||
Hepatitis C Virus NS4 Genotype 5 protein |
|||
| 30R-AH060 | Fitzgerald | 100 ug | EUR 548.4 |
|
Description: Hepatitis C Virus NS4 Mosaic Genotype-5 recombinant protein |
|||
Hepatitis C Virus NS5 Genotype 1a protein |
|||
| 30R-AH064 | Fitzgerald | 500 ug | EUR 967.2 |
|
Description: Hepatitis C Virus NS5 Genotype-1a recombinant protein |
|||
Hepatitis C Virus Genotype 3 NS3 Antibody |
|||
| 33152-05111 | AssayPro | 150 ug | EUR 313.2 |
Hepatitis C Virus Core Genotype 4 protein |
|||
| 30-1949 | Fitzgerald | 500 ug | EUR 967.2 |
|
Description: Hepatitis C Virus Core Genotype-4 recombinant protein |
|||
Hepatitis C Virus NS3 Genotype-1c Protein |
|||
| 20-abx260130 | Abbexa |
|
|
Hepatitis C Virus NS3 Genotype-5a Protein |
|||
| 20-abx260131 | Abbexa |
|
|
Hepatitis C Virus NS5 Genotype-1 Protein |
|||
| 20-abx260132 | Abbexa |
|
|
Hepatitis C Virus NS5 Genotype-3 Protein |
|||
| 20-abx260133 | Abbexa |
|
|
Hepatitis C Virus NS5 Genotype-6 Protein |
|||
| 20-abx260134 | Abbexa |
|
|
Hepatitis C Virus NS5 Genotype-2 Protein |
|||
| 20-abx260135 | Abbexa |
|
|
Hepatitis C Virus NS5 Genotype-4 Protein |
|||
| 20-abx260237 | Abbexa |
|
|
WGS supplied proof of ongoing native transmission of M. bovis among the many dairies on this high-TB burden area of BCA, in addition to present shut relationships between isolates recovered from people, cheese, and cattle. This confirms the necessity for a coordinated One Well being method in addressing the elimination of TB in animals and people. Total, the research contributes to the information of the molecular epidemiology of M. bovis in BCA, offering perception into the pathogen’s dynamics in a excessive prevalence setting.
